Pro-TTVR: Total TR Resolution Must be a Goal and is a Key Factor Impacting Long-Term Outcomes

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Grant Support/Research Contract - Abbott Vascular; Abiomed; Amgen; AstraZenca; Bayer AG; Bbraun; Biotronik; Boehringer Ingelheim; Boston Scientific Corporation; Bristol-Myers Squibb; Cardinal Health; CardioValve; Cordis; Corflow; CSL; Daiici Sankyo; Edwards Lifesciences; Farapulse; Fumedica; Guerbet; Idorsia; Inari Medical; InfraredX; Janssen Pharmaceuticals; Jonson&Johnson; Medalliance; Medicure; Medtronic; Merck Sharp &Dohm; Miracor Medical; Novartis; Novo Nordisk; Organon; Orpha Suisse; Pharming Tech; Pfizer; Poiares; Regeneron; Sanofi Aventis; Servier; sinomed; Terumo Medical Corporation; Vifor; V-Wave